On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
2023 年 10 月 26 日，Tempest Therapeutics 收到了纳斯达克的正式通知，称该公司已恢复遵守纳斯达克 1.00 美元最低价格规则
On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
2023 年 10 月 26 日，Tempest Therapeutics 收到了纳斯达克的正式通知，称该公司已恢复遵守纳斯达克 1.00 美元最低价格规则